<DOC>
	<DOCNO>NCT01774227</DOCNO>
	<brief_summary>- Transcleral cyclophotocoagulation ( TSCPC ) long used refractory glaucoma management easy learn easy perform . - Recent advance laser technology ; role TSCPC expand benefit noninvasive glaucoma procedure . - The titration ( pop ) , fix high-energy , fixed-low energy ( slow-coagulation ) three energy delivery technique . - The present study would report outcome ( efficacy safety ) slow-coagulation versus titration method treatment refractory glaucoma dark iris . - The result would provide reliable evidence supplement clinical judgment make decision favor treatment method glaucoma patient .</brief_summary>
	<brief_title>Pops-titration Versus Slow-coagulation Cyclophotocoagulation Treatment Refractory Glaucoma</brief_title>
	<detailed_description>- Several protocol afford delivery `` optimum '' dose laser energy per session necessary achieve long-term effective ocular hypotensive response balance risk related high energy treatment risk related retreatment due suboptimum dose delivery . - There two main approach deliver laser energy , pops-titration method fix energy method fixed-high low-energy ( Gaasterland 's slow-coagulation technique ) . - Of particular interest laser energy delivery method ( slow-coagulation versus pops-titration ) affords optimal dose photocoagulation necessary achieve effective long-term intraocular pressure ( IOP ) reduction minimize risk adverse event related overtreatment retreatments especially refractory glaucomatous eye dark iris color .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<criteria>Eyes visual potential high intraocular pressure ( maximal medical treatment ) intraocular pressure probably cause corneal complication Eyes visual potential high intraocular pressure ( maximal medical treatment ) intraocular pressure cause eye pain need pain relief Eyes minimal useful vision intraocular pressure target intraocular pressure Eyes trabeculectomy mitomycinC and/or drainage implant high probability failure Eyes trabeculectomy mitomycinC and/or drainage implant previously fail Patient refuse undergo aggressive intraocular surgery Patients whose general medical condition precludes invasive surgery The visual acuity fellow eye light perception Have previously treat transcleral cyclophotocoagulation Allergy anesthetic medication Can measure intraocular pressure applanation method</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Refractory glaucoma</keyword>
	<keyword>Transcleral cyclophotocoagulation ( TSCPC )</keyword>
	<keyword>Dark iris</keyword>
	<keyword>Pops-titration</keyword>
	<keyword>Slow-coagulation</keyword>
</DOC>